Chemical Entrepreneurship Series

Chemical Entrepreneurship Series

Business and Innovation: Chemical Entrepreneurship Series

Dare to dream! Many people dream of starting their own businesses, or being a part of the exciting start-up culture. But do you know what it takes to succeed? A successful business, large or small, takes careful and strategic planning, knowledge of the industry, financial resources, fiscal know-how, legal savvy, and guts. Join our speakers to learn the A-to-Z of being an entrepreneur, finding the right resources, and the challenges/rewards of start-ups. Are you ready?

 

Join us in this 2011 series… Every 3rd Thursday from April to October at 2-3 pm EST!


Click on the date to Register!

Special Feature!

(Join LIVE to maximize your Q&A opportunity with the experts. ACS Webinars recordings will be available a week after the event. Click on the date to access recordings)



Meet Your Experts

Dr. Christine Bellon is currently Vice President of Intellectual Property & Legal Affairs for Hydra Biosciences and is responsible for all legal matters for the company. Dr. Bellon was previously on patent portfolios as Assistant General Counsel, Intellectual Property, for Infinity Pharmaceuticals, as Patent Counsel at Wyeth, and as an attorney in the Boston office of Fish & Richardson P.C. Christine holds a J.D. degree from Columbia Law School, a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology, and is a graduate from Yale University with honors, with a B.S. in Chemistry.

 

Dr. Nick Conti is responsible for the licensing, strategic alliance and business development activities for Quest Diagnostics, a $7 billion diagnostic testing corporation. He has been in business development, management and R&D positions with Becton Dickinson and Union Carbide. He had held visiting and adjunct faculty positions at Rutgers (Chemistry) and Seton Hall (Finance). He serves on several boards of start-ups and is an advisor to funds. He holds a Ph.D. from the University of Florida, a B.S. in Chemistry from Notre Dame, and an MBA from The Wharton School.

 

Chris Curfman, Principal, with McKeon Neunier, Carlin & Curfman, LLC received a BS in Biology and MS in Chemistry from Virginia Tech. Chris then received a PhD in Chemistry from Emory University and JD from Georgia State University. Chris’ extensive scientific background in chemistry and pharmaceuticals, as a researcher, scientific advisor, patent agent, and patent attorney adds considerable depth to his ability to counsel startups, large and small corporations, and universities on all aspects of patent prosecution in pharmaceutical, chemical, and biotechnology-related technologies. Chris has taught several patent law classes and presented numerous seminars. Additionally, Chris was named a Georgia Super Lawyers “Rising Star” by Atlanta Magazine (2006).

 

Dr. Dan Daly is the Director of the Alabama Innovation and Mentoring of Entrepreneurs Center. He has 17 years of experience in the fuel and lubricant businesses where he served as Technology and Business Development Manager. He has led the development of several commercially successful projects and has managed and coordinated fundamental programs at several universities and national laboratories. He received B.S. from Florida State University and his Ph.D. in Physical-Organic Chemistry from the University of Florida.

 

Dr. Stephen Flaim is Founder and President of Flaim Partners Consulting, Cofounder and CEO of CardioCreate, Inc. and Chairman & CEO of OncoFluor, Inc. He is a member of the Board of Directors of the Tech Coast Angels, President of the San Diego Tech Coast Angels, and an Entrepreneur-in-Residence with CONNECT. Steve holds a doctorate in Human Physiology and Pharmacology from the University of California at Davis.


Dr. Andy Gilicinski, Director, Open Innovation Networks at Clorox is an innovation leader with a current focus on creating new open innovation capabilities to accelerate growth. He has a 22-year career in chemicals and consumer packaged goods industries including two successful $30MM+ (year 1 sales) launches, R&D management (including global teams), building technology platforms and developing cross-functional innovation processes. He has a Ph.D. in Analytical Chemistry from University of Wisconsin-Madison and B.S. in Chemistry (with Honors) from University of Illinois at Urbana-Champaign.

 

Elaine Harris is President and co-founder of Breakthrough Marketing Technology. The consultancy leverages state of the art analytics to uncover customer, market and employee insights- not just what people say, but what will motivate them. She has global experience in product and market development, brand strategy and market research in industries ranging from technology to advertising. Elaine holds a BS degree in Chemical Engineering from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business. http://www.linkedin.com/in/elaineharris1

 

Dr. Judith Giordan currently serves as Chairman of VentureWell. Judy is the author of over 200 articles, presentations. Judy is the recipient of the 2010 ACS Garvan-Olin Medal of the American Chemical Society. She received her PhD from the University of Maryland and was an Alexander von Humboldt Post Doctoral Research Fellow at the University of Frankfurt in Germany.


Lynn Leger is a Director of Commercial Development for GreenCentre Canada. She has more than two decades of commercialization experience at DuPont, from automotive coatings to disinfection technologies. She has been a Project and Market Leader for a range of new technologies in the chemical industry and is a named inventor on several patents. Ms. Leger is a certified Six Sigma Green Belt and a recipient of the DuPont Global Sustainable Growth Award and a $EED Grant for Entrepreneurial Development. She is the former Chairperson of the Advisory Board for Canadian Research Institute for Food Safety at the University of Guelph, and has been a frequent speaker for DuPont and GreenCentre Canada.

 

Dr. Carol Nacy co-founded Sequella in 1997 and is CEO and Chairman of the Board. Prior to Sequella, she served as part-time Chief Scientific Officer (CSO) for Anergen, Inc., where she reorganized the scientific staff and positioned the company for acquisition, and served as Executive Vice President and CSO at EntreMed, Inc., serving that company through its successful public offering. Dr. Nacy was Career Scientist and Science Manager at the Walter Reed Army Institute of Research, Washington, DC. She currently serves as a member of the board of directors of several companies and non-profit agencies.

 

Pamela Roach is CEO and co-founder of Breakthrough Marketing Technology a strategic marketing and business consultancy that facilitates fact-based decisions about products, markets, customers and employees. She has strategy development and execution experience in diverse industries including medical devices, technology, and specialty materials. Pam holds an AB from Harvard University and a MBA, Columbia University Business School.

 

 

Joseph Steig, Director, Venture Well is a CFO and adviser to both non-profits and for-profits. He is also NCIIA’s Manager of Venture Development. Joseph is the founder of the angel group, River Valley Investors and serves as CFO of Long River Ventures. Joseph has a background with technology-based start-up, serving primarily in CFO positions, and has worked in sectors as diverse as aquaculture and software. He also has extensive experience in economic development. Joseph has a B.A. from Hampshire College.


Dr. Richard Swatloski is a Licensing Associate and helped establish The University of Alabama’s Office for Technology Transfer. His duties include various aspects of intellectual property protection, management and licensing, agreement development, business creation, and education. He has contributed to 50+ peer-reviewed publications and multiple patents. Dr. Swatloski holds both bachelor’s and Ph.D. degrees in chemistry.


Acknowledgment:
This Series is co-produced with National Collegiate Inventors and Innovators Alliance / Venture Well, ACS Division of Business Development and Management, and ACS Women Chemists Committee.

 

The Fine Print

ACS Webinars™ does not endorse any products or services. The views expressed in these presentations are those of the presenters and do not necessarily reflect the views or policies of the ACS.

One Response to “Chemical Entrepreneurship Series”

  1. Prashant Kumar says:

    Dear Sir/Madam

    Myself, Prashant Kumar has been working in the field of material science since 2008 and synthesized many materials which can be directly used in solar photovoltaic cells. I want to sell my approach through a proper Chanel. Can you please suggest me few colloborators names to whom i can contact or guide how should i proceed in this direction.

    Thank you

    With regards

    Prashant Kumar(M.Phil.)
    Research Scholar
    Department of Chemistry
    University of Delhi
    Delhi

Leave a Comment


5 − = 4